A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

Clinical trial NCT07462143 · RECRUITING

Trial details

NCT number: NCT07462143
Sponsor: RemeGen Co., Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colorectal (Colon or Rectal) Cancer

Start date: 2026-05-12
Primary completion: 2027-05-12
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.